Personalized Medicine Market Trends and Prospects

1
Personalized Medicine - Opening Doors and
Overcoming Challenges
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Over the last 20 years personalized medicine has
  grown as tool in patient treatment. Personalized
  medicine uses a patients genetic information to
  help tailor treatment to avoid side effects,
  identify what treatments will and wont work and
  establish a pre-disposition towards certain
  diseases. Personalized medicine has been focused
  to a great degree in the oncology area, where on
  average an individual patient may find more than
  70 of medicines ineffective for them. In the
  last few years this has begun to change as more
  personalized medicines have been developed
  outside of the oncology field. The spread of
  personalized medicine to other fields has
  increased the challenge of physician uptake, with
  many GPs not feeling comfortable ordering genetic
  tests. Personalized medicine faces a number of
  road blocks, including the issues of physician
  uptake of diagnostics, challenges for clinical
  trials, public controversy and, most
  significantly, lack of reimbursement by payers.
• Scope
• Overview and timeline of personalized medicine
• Issues and case studies related to personalized
  medicine
• Key topics covered include identification of
  adverse reactions, identification of
  pre-disposition towards diseases and treatment
  options that will and will not work
• Healthcare legislation related to personalized
  medicine
• Challenges and strategies to overcome
• Future outlook
• Read More At http//www.researchbeam.com/persona
  lized-medicine-opening-doors-and-overcoming-challe
  nges-market

3


Table of Content

• Executive SummaryIntroductionWhat is
  Personalized MedicineTimeline of Personalized
  MedicineThe Spectrum of Personalized
  MedicineIdentifying Adverse ReactionsControversy
  /IssuesCase Study warfarinCase Study
  ZiagenIdentifying What Treatment will
  WorkControversy/IssuesCase Study
  HerceptinCase Study ErbituxIdentifying What
  Treatment wont WorkControversy/IssuesCase
  Study Plavix Case Study beta interferon 
• Identifying Pre-disposition towards
  diseaseControversy/IssuesCase Study Breast
  Cancer Case Study Alzheimers Disease

4


Table of Content
Health care Legislation and Personalized
MedicineHealth Insurance Portability and
Accountability Act 1996 Genetic Information
Non-discrimination Act 2008Patient Protection
and Affordable Care/Health Care Education and
Reconciliation 2010Comparative Effectiveness
ResearchShift of the system to paying for
outcomesRe-focus towards preventionRoad Blocks
and AnswersPhysician UptakePublic
ControversyEducationChallenges for Clinical
TrialsBenefits for Clinical TrialsReimbursement
Co-developmentThe Personalized Medicine
OutlookTechnology DevelopmentsTesting
PriceShifting StrategyWhere do We Go From
HereAppendix Enquire At http//www.researchbeam.
com/personalized-medicine-opening-doors-and-overco
ming-challenges-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/personalized-medicine-
opening-doors-and-overcoming-challenges-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com